[{"OtherAccruedLiabilitiesCurrent_0_Q1_USD":11844000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":25236000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":62307000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":26217000.0,"InterestExpense_1_Q1_USD":6204000.0,"ProfitLoss_1_Q1_USD":-138651000.0,"LiabilitiesCurrent_0_Q1_USD":377471000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":1887933000.0,"Liabilities_0_Q1_USD":591507000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":24211000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":130672000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":227035000.0,"Cash_0_Q1_USD":5994000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":227035000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":900000.0,"ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_1_Q1_USD":0.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q1_USD":185900000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q1_USD":1118847000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_1_Q1_USD":241068000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":3306655000.0,"InterestPaidNet_1_Q1_USD":4951000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_1_Q1_USD":439735000.0,"SeniorNotes_0_Q1_USD":254800000.0,"NonoperatingIncomeExpense_1_Q1_USD":-4820000.0,"OtherLiabilitiesCurrent_0_Q1_USD":1459000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":108987000.0,"StockIssuedDuringPeriodSharesShareBasedCompensation_1_Q1_shares":49000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":133901000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":142297000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":15613000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q1_USD":11347000.0,"OperatingIncomeLoss_1_Q1_USD":-133631000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q1_USD":2133000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1_Q1_USD":-97000.0,"CostsAndExpenses_1_Q1_USD":184204000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-2003369000.0,"SeniorNotesCurrent_0_Q1_USD":254144000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":50573000.0,"CostOfGoodsAndServicesSold_1_Q1_USD":3811000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.78,"NumberOfOperatingSegments_1_Q1_Segment":1.0,"StockholdersEquity_0_Q1_USD":1296426000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":177185000.0,"Goodwill_0_Q1_USD":76501000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_1_Q1_USD":11077000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-6877000.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":-2510000.0,"ContractWithCustomerLiability_0_Q1_USD":5561000.0,"DepreciationAndAmortization_1_Q1_USD":4502000.0,"AccountsReceivableNetCurrent_0_Q1_USD":42031000.0,"IncreaseDecreaseInOtherOperatingLiabilities_1_Q1_USD":-233000.0,"IncreaseDecreaseInOtherOperatingAssets_1_Q1_USD":-1067000.0,"IncreaseDecreaseInOtherAccruedLiabilities_1_Q1_USD":7716000.0,"IncreaseDecreaseInInventories_1_Q1_USD":1655000.0,"AccountsPayableCurrent_0_Q1_USD":21789000.0,"InventoryWorkInProcessNetOfReserves_0_Q1_USD":11463000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":22412000.0,"InventoryRawMaterialsNetOfReserves_0_Q1_USD":1198000.0,"InventoryNet_0_Q1_USD":14320000.0,"InventoryFinishedGoodsNetOfReserves_0_Q1_USD":1659000.0,"InterestReceivableCurrent_0_Q1_USD":6200000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_1_Q1_USD":9920000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":-5872000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q1_USD":-751000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q1_USD":-5121000.0,"OtherAssetsCurrent_0_Q1_USD":13811000.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":3007000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q1_USD":2554000.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q1_USD":2510000.0,"ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_1_Q1_USD":44600000.0,"NetIncomeLoss_1_Q1_USD":-138651000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-78075000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":197767000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":11077000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-144523000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":5229000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":2687000.0,"CommonStockValue_0_Q1_USD":17000.0,"CommonStockSharesOutstanding_0_Q1_shares":177863000.0,"OtherNoncashIncomeExpense_1_Q1_USD":1289000.0,"CommonStockSharesAuthorized_0_Q1_shares":300000000.0,"PreferredStockValue_0_Q1_USD":0.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"PreferredStockSharesAuthorized_0_Q1_shares":10000000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"CommitmentsAndContingencies_0_Q1_USD":null,"IncomeTaxExpenseBenefit_1_Q1_USD":200000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":-138451000.0,"AssetsCurrent_0_Q1_USD":1429324000.0,"Assets_0_Q1_USD":1887933000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"OtherNonoperatingIncomeExpense_1_Q1_USD":8352000.0,"Ticker":"NKTR","CIK":"906709","name":"NEKTAR THERAPEUTICS","OfficialName":"Nektar Therapeutics  Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"862449342.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200508"}]